Form 4: Intensity Therapeutics Principal Accounting Officer Acquires Stock Options

John M. Wesolowski, Principal Accounting Officer of Intensity Therapeutics, Inc., reports the acquisition of stock options exercisable for 100,000 shares of common stock.

Summary

• John M. Wesolowski, the Principal Accounting Officer of Intensity Therapeutics, Inc. (INTS), filed a Form 4 with the SEC on May 6, 2025.
• The form reports the acquisition of stock options to purchase 100,000 shares of INTS common stock on May 2, 2025.
• The exercise price of the options is $0.57 per share.
• The options vest in five equal annual installments starting on May 2, 2025, and expire on May 2, 2035.
• Wesolowski also has a power of attorney on file, executed on October 29, 2024, allowing designated individuals to file Section 16 forms on his behalf.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing. Insider confidence is implied, but not explicitly stated.

Positives

• The acquisition of stock options by a company officer can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The acquisition of stock options by a company officer may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Form 4, Intensity Therapeutics, Stock Options, Beneficial Ownership, Wesolowski, INTS, Section 16